23andMe Stock Falls 59% After Bankruptcy Filing
23andMe stock has actually plummeted dramatically, right now, following the company’s bankruptcy filing announcement, raising some serious concerns about genetic data privacy and also the future of this once-promising biotech company. The personalized genomics firm, which currently holds DNA data from approximately 15 million customers, saw its shares fall 59% on Monday, followed by an additional 11% drop on Tuesday as investors reacted to the news. Also Read: Shiba Inu: SHIB April 2025 Price Prediction 23andMe Bankruptcy Shakes Biotech—DNA Data & Investor Panic Source: Mashable The bankruptcy filing has, at the time of writing, triggered some widespread uncertainty about what will happen to 23andMe’s most valuable asset: the genetic data that was collected from millions of customers who submitted saliva samples for Analysis . This data was also previously protected under some contractual agreements between the company and its customers, but the bankruptcy proceedings have...